Next Article in Journal
The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?
Next Article in Special Issue
An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Previous Article in Journal
Progress and Challenges to Hepatitis E Vaccine Development and Deployment
Previous Article in Special Issue
Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice
 
 
Article

Article Versions Notes

Vaccines 2024, 12(7), 720; https://doi.org/10.3390/vaccines12070720
Action Date Notes Link
article xml file uploaded 28 June 2024 11:11 CEST Original file -
article xml uploaded. 28 June 2024 11:11 CEST Update -
article pdf uploaded. 28 June 2024 11:11 CEST Version of Record https://www.mdpi.com/2076-393X/12/7/720/pdf-vor
article html file updated 28 June 2024 11:13 CEST Original file -
article pdf uploaded. 5 August 2024 09:52 CEST Minor correction https://www.mdpi.com/2076-393X/12/7/720/pdf
article xml uploaded. 5 August 2024 09:52 CEST Minor correction -
article xml uploaded. 5 August 2024 09:52 CEST Minor correction https://www.mdpi.com/2076-393X/12/7/720/xml
article html file updated 5 August 2024 09:54 CEST Update https://www.mdpi.com/2076-393X/12/7/720/html
Back to TopTop